$NBSE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NeuBase Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NeuBase Therapeutics, Inc.. Get notifications about new insider transactions in NeuBase Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.66 | 200 | 732 | 861,404 | 861.2 K to 861.4 K (+0.02 %) |
Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.67 | 200 | 734 | 861,204 | 861 K to 861.2 K (+0.02 %) |
Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.70 | 100 | 370 | 861,004 | 860.9 K to 861 K (+0.01 %) |
Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.73 | 200 | 746 | 860,904 | 860.7 K to 860.9 K (+0.02 %) |
Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.75 | 400 | 1,500 | 860,704 | 860.3 K to 860.7 K (+0.05 %) |
Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.81 | 500 | 1,905 | 860,304 | 859.8 K to 860.3 K (+0.06 %) |
Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.88 | 200 | 776 | 859,804 | 859.6 K to 859.8 K (+0.02 %) |
Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.92 | 100 | 392 | 859,604 | 859.5 K to 859.6 K (+0.01 %) |
Jan 11 2016 | OHRP | Ohr Pharmaceutical ... | HIRSCHMAN ORIN | Director | Option Exercise | A | 5.14 | 60,000 | 308,400 | 60,000 | |
Jan 11 2016 | OHRP | Ohr Pharmaceutical ... | Almenoff June Sherie | Director | Option Exercise | A | 5.14 | 60,000 | 308,400 | 60,000 | |
Jan 11 2016 | OHRP | Ohr Pharmaceutical ... | Riedhammer Thomas M | Director | Option Exercise | A | 5.14 | 60,000 | 308,400 | 60,000 | |
Jan 11 2016 | OHRP | Ohr Pharmaceutical ... | GREENSTEIN IRA A | Director | Option Exercise | A | 5.14 | 60,000 | 308,400 | 60,000 | |
Jan 11 2016 | OHRP | Ohr Pharmaceutical ... | Backenroth Samuel | Chief Financial Off ... | Grant | A | 0.00 | 130,000 | 0 | 136,199 | 6.2 K to 136.2 K (+2,097.11 %) |
Jan 11 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Grant | A | 0.00 | 350,358 | 0 | 859,504 | 509.1 K to 859.5 K (+68.81 %) |
Dec 17 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | J | 0.00 | 497,859 | 0 | 697,865 | 200 K to 697.9 K (+248.92 %) |
Dec 08 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 4.00 | 200 | 800 | 509,146 | 508.9 K to 509.1 K (+0.04 %) |
Dec 08 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 4.02 | 800 | 3,216 | 508,946 | 508.1 K to 508.9 K (+0.16 %) |
Dec 08 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 4.05 | 300 | 1,215 | 508,146 | 507.8 K to 508.1 K (+0.06 %) |
Dec 08 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 4.07 | 300 | 1,221 | 507,846 | 507.5 K to 507.8 K (+0.06 %) |
Dec 08 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 4.10 | 100 | 410 | 507,546 | 507.4 K to 507.5 K (+0.02 %) |
Dec 08 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 4.12 | 1,200 | 4,944 | 507,446 | 506.2 K to 507.4 K (+0.24 %) |
Dec 08 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 4.13 | 100 | 413 | 506,246 | 506.1 K to 506.2 K (+0.02 %) |
Nov 24 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | J | 0.00 | 428,223 | 0 | 506,146 | 77.9 K to 506.1 K (+549.55 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.01 | 100 | 301 | 77,923 | 77.8 K to 77.9 K (+0.13 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.03 | 1,400 | 4,242 | 77,823 | 76.4 K to 77.8 K (+1.83 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.03 | 200 | 606 | 76,423 | 76.2 K to 76.4 K (+0.26 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.02 | 200 | 604 | 76,223 | 76 K to 76.2 K (+0.26 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.02 | 200 | 604 | 76,023 | 75.8 K to 76 K (+0.26 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.01 | 1,300 | 3,913 | 75,823 | 74.5 K to 75.8 K (+1.74 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.00 | 2,600 | 7,800 | 74,523 | 71.9 K to 74.5 K (+3.61 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.00 | 300 | 900 | 71,923 | 71.6 K to 71.9 K (+0.42 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.00 | 700 | 2,100 | 71,623 | 70.9 K to 71.6 K (+0.99 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.99 | 2,600 | 7,774 | 70,923 | 68.3 K to 70.9 K (+3.81 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.99 | 1,800 | 5,382 | 68,323 | 66.5 K to 68.3 K (+2.71 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.99 | 750 | 2,242 | 66,523 | 65.8 K to 66.5 K (+1.14 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.98 | 400 | 1,192 | 65,773 | 65.4 K to 65.8 K (+0.61 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.98 | 300 | 894 | 65,373 | 65.1 K to 65.4 K (+0.46 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.97 | 500 | 1,485 | 65,073 | 64.6 K to 65.1 K (+0.77 %) |
Mar 12 2015 | OHRP | Ohr Pharmaceutical ... | Almenoff June Sherie | Director | Option Exercise | A | 10.14 | 84,000 | 851,760 | 84,000 | |
Mar 12 2015 | OHRP | Ohr Pharmaceutical ... | HIRSCHMAN ORIN | Director | Option Exercise | A | 10.14 | 84,000 | 851,760 | 84,000 | |
Mar 12 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Director | Option Exercise | A | 10.14 | 50,000 | 507,000 | 50,000 | |
Mar 12 2015 | OHRP | Ohr Pharmaceutical ... | GREENSTEIN IRA A | Director | Option Exercise | A | 10.14 | 84,000 | 851,760 | 84,000 | |
Mar 12 2015 | OHRP | Ohr Pharmaceutical ... | Riedhammer Thomas M | Director | Option Exercise | A | 10.14 | 84,000 | 851,760 | 84,000 | |
Mar 12 2015 | OHRP | Ohr Pharmaceutical ... | Taraporewala Irach B. | Chief Executive Off ... | Option Exercise | A | 10.14 | 75,000 | 760,500 | 75,000 | |
Mar 12 2015 | OHRP | Ohr Pharmaceutical ... | Backenroth Samuel | Chief Financial Off ... | Option Exercise | A | 10.14 | 60,000 | 608,400 | 60,000 | |
Feb 10 2015 | OHRP | Ohr Pharmaceutical ... | Backenroth Samuel | Chief Financial Off ... | Buy | P | 6.75 | 1,500 | 10,125 | 6,199 | 4.7 K to 6.2 K (+31.92 %) |
Feb 10 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Director | Buy | P | 6.75 | 29,630 | 200,003 | 64,573 | 34.9 K to 64.6 K (+84.80 %) |
Feb 10 2015 | OHRP | Ohr Pharmaceutical ... | Taraporewala Irach B. | Chief Executive Off ... | Buy | P | 6.75 | 3,705 | 25,009 | 22,800 | 19.1 K to 22.8 K (+19.40 %) |
Feb 10 2015 | OHRP | Ohr Pharmaceutical ... | Almenoff June Sherie | Director | Buy | P | 6.75 | 6,000 | 40,500 | 16,900 | 10.9 K to 16.9 K (+55.05 %) |
Jan 16 2015 | OHRP | Ohr Pharmaceutical ... | GREENSTEIN IRA A | Director | Option Exercise | X | 1.65 | 66,667 | 110,001 | 100,000 | |
Jan 16 2015 | OHRP | Ohr Pharmaceutical ... | GREENSTEIN IRA A | Director | Buy | X | 1.65 | 54,659 | 90,187 | 431,051 | 376.4 K to 431.1 K (+14.52 %) |
Dec 08 2014 | OHRP | Ohr Pharmaceutical ... | Taraporewala Irach B. | CEO & President | Option Exercise | A | 10.11 | 250,000 | 2,527,500 | 771,596 | |
Dec 08 2014 | OHRP | Ohr Pharmaceutical ... | Backenroth Samuel | CFO & VP of Bus. De ... | Option Exercise | A | 10.11 | 250,000 | 2,527,500 | 454,700 | |
Sep 10 2014 | OHRP | Ohr Pharmaceutical ... | HIRSCHMAN ORIN | Director | Option Exercise | C | 6.75 | 337,481 | 2,277,997 | 129,000 | |
Sep 10 2014 | OHRP | Ohr Pharmaceutical ... | HIRSCHMAN ORIN | Director | Buy | C | 6.75 | 71,888 | 485,244 | 1,750,748 | 1.7 M to 1.8 M (+4.28 %) |
Sep 10 2014 | OHRP | Ohr Pharmaceutical ... | GREENSTEIN IRA A | Director | Option Exercise | C | 6.75 | 28,743 | 194,015 | 166,667 | |
Sep 10 2014 | OHRP | Ohr Pharmaceutical ... | GREENSTEIN IRA A | Director | Buy | C | 6.75 | 6,123 | 41,330 | 443,059 | 436.9 K to 443.1 K (+1.40 %) |
Sep 04 2014 | OHRP | Ohr Pharmaceutical ... | Almenoff June Sherie | Director | Buy | P | 8.05 | 1,200 | 9,660 | 127,566 | 126.4 K to 127.6 K (+0.95 %) |
Sep 04 2014 | OHRP | Ohr Pharmaceutical ... | Almenoff June Sherie | Director | Buy | P | 8.12 | 1,000 | 8,120 | 126,366 | 125.4 K to 126.4 K (+0.80 %) |
Jul 03 2014 | OHRP | Ohr Pharmaceutical ... | GREENSTEIN IRA A | Director | Buy | P | 8.40 | 1,000 | 8,400 | 456,496 | 455.5 K to 456.5 K (+0.22 %) |
Jun 30 2014 | OHRP | Ohr Pharmaceutical ... | Almenoff June Sherie | Director | Buy | P | 8.34 | 3,200 | 26,688 | 125,366 | 122.2 K to 125.4 K (+2.62 %) |
Apr 21 2014 | OHRP | Ohr Pharmaceutical ... | Riedhammer Thomas M | Director | Buy | P | 10.36 | 1,100 | 11,396 | 117,767 | 116.7 K to 117.8 K (+0.94 %) |
Jun 27 2014 | OHRP | Ohr Pharmaceutical ... | Riedhammer Thomas M | Director | Buy | P | 7.39 | 6,900 | 50,991 | 124,667 | 117.8 K to 124.7 K (+5.86 %) |
Apr 10 2014 | OHRP | Ohr Pharmaceutical ... | GREENSTEIN IRA A | Director | Buy | P | 10.20 | 2,500 | 25,500 | 455,496 | 453 K to 455.5 K (+0.55 %) |
Apr 09 2014 | OHRP | Ohr Pharmaceutical ... | Almenoff June Sherie | Director | Buy | P | 10.25 | 5,500 | 56,375 | 122,166 | 116.7 K to 122.2 K (+4.71 %) |